Pediatric diabetes consortium T1D New Onset (NeOn) study: Clinical outcomes during the first year following diagnosis

Pediatric Diabetes

Volumn 15, Issue 4, 2014, Pages 287-293

  Cengiz, Eda ^a   Connor, Crystal G ^b   Ruedy, Katrina J ^b   Beck, Roy W ^b   Kollman, Craig ^b   Klingensmith, Georgeanna J ^c   Tamborlane, William V ^a   Lee, Joyce M ^d,e   Haller, Michael J ^f   Haymond, Morey ^g   Redondo, Maria J ^g   Hassan, Krishna ^g   Shippy, Kathy ^g   George, Chris ^g   Pontifes, Mariam ^g   Wood, Jamie ^h   Ichihara, Brian ^h   Lipton, Megan ^h   Cohen, Marisa ^h   Buckingham, Bruce ⁱ   Harris, Breanne ⁱ   Shanmugham, Satya ⁱ   Klingensmith J , Georgeanna ^j   Cruz, Eric ^j   Haro, Heidi ^j   King, Maria ^j   Manseau, Katherine ^j   Schatz, Desmond ^f   Silverstein, Janet ^f   Haller J , Michael ^f   Dougherty, Erica ^f   Tamborlane V , William ^a   Martin, Melody ^a   Steffen, Amy ^a   Carria, Lori ^a   Cappiello, Darryll ^a   Lee M , Joyce ^e   Bashir, Surair ^e   Eason, Ashley ^e   Beck W , Roy ^b   Ruedy J , Katrina ^b   Connor G , Crystal ^b   Stevens, Beth ^b   more..

^a YALE UNIVERSITY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h CHILDREN S HOSPITAL LOS ANGELES   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Children; Diabetes; HbA1c or glycemic control

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CARBOHYDRATE INTAKE; CHILD; CHILDHOOD DISEASE; CONSCIOUSNESS DISORDER; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SEIZURE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; DRUG MONITORING; EPIDEMIOLOGY; FOLLOW UP; HYPERGLYCEMIA; INCIDENCE; INFANT; KAPLAN MEIER METHOD; MULTICENTER STUDY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INFANT; INSULIN; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84901611572     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12068     Document Type: Article

References (21)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177-188.
3. Martin CL, Albers J, Herman WH et al. Neuropathy among the diabetes control and complications trial cohort 8years after trial completion. Diabetes Care 2006: 29: 340-344.
4. Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002: 25: 1185-1191.
5. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012: 97: 4383-4389.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011: 34 (Suppl. 1): S62-69.
7. Pediatric Diabetes Consortium. The pediatric diabetes consortium: improving care of children with type 1 diabetes through collaborative research. Diabetes Technol Ther 2010: 12: 685-688.
8. Kuczmarski R, Ogden C, Grummer-Strawn L et al. CDC growth charts: United States. Adv Data 2000: 314: 1-27.
9. Mortensen HB, Hougaard P, Swift P et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 2009: 32: 1384-1390.
10. Couper JDK. Phases of diabetes in children and adolescents. Pediatr Diabetes 2009: 10: 13-16.
11. Lombardo FVM, Wasniewska M, Messina MF, Ruggeri C, Arrigo T, De Luca F. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab 2002: 15: 246-251.
12. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell R et al. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716-2724.
13. Mortensen HB, Swift PG, Holl RW et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12months after diagnosis. Pediatr Diabetes 2010: 11: 218-226.
14. Ramchandani N, Ellis MK, Jain S et al. Basal insulin requirements on continuous subcutaneous insulin infusion during the first 12months after diagnosis of type1 diabetes mellitus. J Diabetes Sci Technol 2010: 4: 610-614.
15. Salemyr J, Bang P, Örtqvist E. Lower HbA1c after 1year, in children with type 1 diabetes treated with insulin glargine vs NPH insulin from diagnosis: a retrospective study. Pediatr Diabetes. 2011: 12: 501-505.
16. Beck JK, Lewis TV, Logan KJ, Harrison DL, Gardner AW, Copeland KC. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: should payer source influence the choice of therapy? Pediatr Diabetes 2009: 10: 368-373.
17. Bowden SA, Duck MM, Hoffman RP. Young children (<5yr) and adolescents (>12yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes 2008: 9: 197-201.
18. Chase HP, MacKenzie TA, Burdick J et al. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes 2004: 5: 16-19.
19. Palta M, Shen G, Allen C, Klein R, D'Lessio D, the Wisconsin Diabetes Registry. Longitudinal Patterns of Glycemic Control and Diabetes Care from Diagnosis in a Population-based Cohort with Type 1 Diabetes. Am J Epidemiol 1996: 144: 954-961.
20. Yki-Järvinen H, Koivisto V. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab 1984: 59: 371-378.
21. Yki-Järvinen H, Koivisto V. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986: 315: 224-230.